Insider Trading History of Reich Siegfried

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Reich Siegfried since 2007. This trader's CIK number is 1351888. At the time of last reporting, Reich Siegfried was the EVP & Chief Scientific Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX). Also see all insider trading activities at Turning Point Therapeutics, Inc..

Note that in the past Reich Siegfried also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Reich Siegfried

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 TPTX 0 $0 397 $14,411 0 $0
2021 TPTX 0 $0 35,550 $3,786,643 35,550 $1,823,004

Yearly summary of insider trading at Sgx Pharmaceuticals, Inc. (SGXP) by Reich Siegfried

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 SGXP 0 $0 7,029 $20,953 14,063 $0
2007 SGXP 0 $0 17,966 $80,596 35,937 $0


Insider trading activities at 2 companies by Reich Siegfried:

1. Turning Point Therapeutics, Inc. (TPTX)

2. Sgx Pharmaceuticals, Inc. (SGXP)

Table 1. Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Reich Siegfried

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-09 TPTX Sale 397 36.30 14,411
2021-03-04 TPTX Option Ex 35,550 51.28 1,823,004
2021-03-04 TPTX Sale 35,550 106.52 3,786,643

Table 2. Insider trading of Sgx Pharmaceuticals, Inc. (SGXP) by Reich Siegfried

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-08-15 SGXP Option Ex 1,562 .00 0
2008-08-15 SGXP Sale 781 2.98 2,327
2008-07-15 SGXP Sale 781 3.06 2,385
2008-07-15 SGXP Option Ex 1,563 .00 0
2008-06-16 SGXP Option Ex 1,562 .00 0
2008-06-16 SGXP Sale 781 1.65 1,288
2008-05-15 SGXP Sale 781 1.45 1,132
2008-05-15 SGXP Option Ex 1,563 .00 0
2008-04-15 SGXP Sale 781 1.19 929
2008-04-15 SGXP Option Ex 1,562 .00 0
2008-03-17 SGXP Option Ex 1,563 .00 0
2008-03-17 SGXP Sale 781 4.01 3,131
2008-03-17 SGXP Option Ex 1,563 .00 0
2008-03-17 SGXP Sale 781 4.01 3,131
2008-02-15 SGXP Sale 781 4.05 3,163
2008-02-15 SGXP Option Ex 1,562 .00 0
2008-01-15 SGXP Option Ex 1,563 .00 0
2008-01-15 SGXP Sale 781 4.44 3,467
2007-12-17 SGXP Option Ex 1,562 .00 0
2007-12-17 SGXP Sale 781 4.75 3,709
2007-11-15 SGXP Option Ex 1,563 .00 0
2007-11-15 SGXP Sale 781 5.10 3,983
2007-10-15 SGXP Option Ex 1,562 .00 0
2007-10-15 SGXP Sale 781 6.42 5,014
2007-09-17 SGXP Sale 781 6.20 4,842
2007-09-17 SGXP Option Ex 1,563 .00 0
2007-08-15 SGXP Option Ex 1,562 .00 0
2007-08-15 SGXP Sale 781 6.42 5,017
2007-07-16 SGXP Sale 781 6.05 4,725
2007-07-16 SGXP Option Ex 1,563 .00 0
2007-06-15 SGXP Sale 781 5.15 4,019
2007-06-15 SGXP Option Ex 1,562 .00 0
2007-05-15 SGXP Option Ex 1,563 .00 0
2007-05-15 SGXP Sale 781 5.18 4,049
2007-04-16 SGXP Option Ex 1,562 .00 0
2007-04-16 SGXP Sale 781 5.02 3,922
2007-03-15 SGXP Sale 781 5.53 4,318
2007-03-15 SGXP Option Ex 1,563 .00 0
2007-02-15 SGXP Option Ex 1,562 .00 0
2007-02-15 SGXP Sale 781 5.36 4,186
2007-01-16 SGXP Option Ex 18,750 .00 0
2007-01-16 SGXP Sale 9,375 3.50 32,812

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reich Siegfried (EVP & Chief Scientific Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.